Valuation Metrics: A Closer Look
As of 3 June 2026, Elixir Capital's P/E ratio stands at 20.68, a significant moderation from previous levels that had placed the stock in the very expensive category. This figure now aligns more closely with the broader NBFC sector's valuation spectrum, where peers exhibit a wide range of P/E ratios—from the highly elevated 111.26 of Ashika Credit to the more modest 7.69 of Satin Creditcare.
The company's price-to-book value has also adjusted to 1.06, indicating that the stock is trading near its book value, a stark contrast to the premium multiples seen in some of its sector counterparts. This shift to a fair valuation grade is further supported by the enterprise value to EBITDA (EV/EBITDA) ratio of 13.21, which, while higher than some peers like Satin Creditcare (6.43), remains reasonable within the NBFC universe.
Other valuation metrics such as EV to EBIT (14.31) and EV to Capital Employed (1.04) reinforce the narrative of a stock that has become more reasonably priced relative to its earnings and capital base. The PEG ratio remains at zero, reflecting either a lack of meaningful earnings growth expectations or a flat growth outlook, which investors should weigh carefully.
Comparative Peer Analysis
When benchmarked against its peers, Elixir Capital's valuation appears balanced. While Meghna Infracon and Arman Financial remain very expensive with P/E ratios exceeding 29 and EV/EBITDA multiples well above 10, companies like Satin Creditcare and SMC Global Securities offer more attractive valuations with P/E ratios below 13 and EV/EBITDA multiples under 7.
This positioning suggests that Elixir Capital is no longer overvalued relative to its sector, but it does not yet offer the deep value seen in some more attractively priced NBFCs. Investors seeking a blend of moderate valuation and growth potential may find Elixir Capital's current metrics compelling, especially given its recent performance trends.
This week's disclosed pick, a Large Cap from NBFC, comes with precise Target Price and analysis. Check if you're positioned right for this opportunity!
- - Precise target price set
- - Weekly selection live
- - Position check opportunity
Financial Performance and Returns Context
Elixir Capital's return profile over various time horizons provides additional context to its valuation shift. The stock has delivered a robust 168.19% return over three years and an impressive 223.84% over five years, substantially outperforming the Sensex's 19.35% and 43.97% returns over the same periods respectively. Even over a decade, the stock's 200.84% gain surpasses the Sensex's 178.10%.
However, more recent performance has been mixed. Year-to-date, Elixir Capital has gained 9.09%, outperforming the Sensex's decline of 12.40%. Conversely, over the past year, the stock has declined 4.34%, though this is less severe than the Sensex's 8.26% fall. Shorter-term returns have been negative, with a 3.87% drop over the past week and a 1.37% decline over the last month, indicating some near-term volatility.
Profitability and Efficiency Metrics
Profitability ratios remain modest, with the latest return on capital employed (ROCE) at 7.30% and return on equity (ROE) at 5.13%. These figures suggest moderate efficiency in generating returns from capital and equity, which may partly explain the cautious market valuation. Dividend yield stands at 1.11%, offering a modest income component to shareholders.
While these metrics do not signal exceptional profitability, they are consistent with a micro-cap NBFC navigating a competitive and regulatory-intensive environment. Investors should consider these fundamentals alongside valuation improvements when assessing the stock's attractiveness.
Price Movement and Market Sentiment
On 3 June 2026, Elixir Capital's stock price closed at ₹108.00, up 3.10% from the previous close of ₹104.75. The intraday range was ₹103.05 to ₹112.95, reflecting active trading interest. The 52-week high and low stand at ₹143.80 and ₹78.10 respectively, indicating a wide trading band and potential for volatility.
This recent price appreciation aligns with the valuation grade upgrade from Sell to Strong Sell on 2 April 2025, signalling a market reassessment of the stock's risk-reward profile. The micro-cap status and sector-specific challenges continue to temper enthusiasm, but the improved valuation metrics provide a foundation for renewed investor interest.
Sector and Industry Considerations
Within the NBFC sector, valuation disparities are pronounced, driven by differences in asset quality, growth prospects, and regulatory compliance. Elixir Capital's fair valuation contrasts with very expensive peers such as Meghna Infracon and Kalind, whose P/E ratios exceed 30 and EV/EBITDA multiples are significantly elevated. Meanwhile, companies like Satin Creditcare and Dolat Algotech offer more attractive valuations but may carry different risk profiles.
Investors should weigh Elixir Capital's valuation improvement against sector headwinds, including interest rate fluctuations, credit demand variability, and evolving regulatory frameworks. The stock's moderate profitability and stable dividend yield may appeal to those seeking a balanced exposure within the NBFC space.
Is Elixir Capital Ltd your best bet? SwitchER suggests better alternatives across peers, market caps, and sectors. Discover stocks that could deliver more for your portfolio!
- - Better alternatives suggested
- - Cross-sector comparison
- - Portfolio optimization tool
Outlook and Investor Takeaways
Elixir Capital's transition from a very expensive to a fair valuation grade marks a pivotal moment for investors evaluating the stock. The recalibrated P/E and P/BV ratios, combined with reasonable EV/EBITDA multiples, suggest the stock is now priced more in line with its fundamentals and sector peers.
However, the modest profitability metrics and zero PEG ratio indicate limited growth expectations, which may constrain upside potential. The stock's micro-cap status and sector-specific risks warrant a cautious approach, particularly for risk-averse investors.
Long-term investors who have benefited from Elixir Capital's strong multi-year returns may view the current valuation as a consolidation phase, while new entrants might consider the stock a fair-value opportunity within the NBFC space. Continuous monitoring of earnings growth, asset quality, and regulatory developments will be essential to reassess the stock's investment merit.
Summary
In summary, Elixir Capital Ltd's valuation adjustment to a fair grade reflects a more attractive price point relative to its historical premium and sector peers. The stock's recent price gains, solid long-term returns, and moderate dividend yield complement this improved valuation narrative. Nonetheless, investors should remain mindful of the company's modest profitability and the broader NBFC sector challenges when considering exposure.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
